DexCom
DXCM
DXCM
315 hedge funds and large institutions have $5.58B invested in DexCom in 2016 Q4 according to their latest regulatory filings, with 80 funds opening new positions, 112 increasing their positions, 91 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
29% less capital invested
Capital invested by funds: $7.81B → $5.58B (-$2.23B)
57% less funds holding in top 10
Funds holding in top 10: 7 → 3 (-4)
92% less call options, than puts
Call options by funds: $30.6M | Put options by funds: $396M
Holders
315
Holding in Top 10
3
Calls
$30.6M
Puts
$396M
Top Buyers
| 1 | +$106M | |
| 2 | +$81.9M | |
| 3 | +$67.9M | |
| 4 |
Morgan Stanley
New York
|
+$60.4M |
| 5 |
FAM
Fred Alger Management
New York
|
+$48.4M |
Top Sellers
| 1 | -$143M | |
| 2 | -$122M | |
| 3 | -$81.5M | |
| 4 |
BM
Bridger Management
New York
|
-$47.2M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$44.8M |